Type
1.
Ramírez-Perea N, Moran-Castaño C, Perez-Molina JA. Should prophylaxis against Pneumocystis jirovecii pneumonia be considered in selected patients with leprosy reactions?. Pneumonia (Nathan Qld.) [Internet]. 2024;16(1):1-3. Available from: https://pneumonia.biomedcentral.com/counter/pdf/10.1186/s41479-024-00127-x.pdf
Type
1.
Shen L, Ding J, Wang Y, Fan W, Feng X, Liu K, et al. Spatial-temporal trends in leprosy burden and its associations with socioeconomic and physical geographic factors: results from the Global Burden of Disease Study 2019. Public health. 2024;230:172-8.
Type
1.
Kolahi S, Ghadakchi L, Sarmadian AJ, Azimi H, Jafarpour M, Khalaji A. Challenging in leprosy relapse with antiphospholipid syndrome diagnosis: A case report. Clinical case reports [Internet]. 2024;12(4):1-6. Available from: https://onlinelibrary.wiley.com/doi/epdf/10.1002/ccr3.8705
Type
1.
Udo S, Ogbu PS, Tsaku PA, Tukur A, NewMarch A. An evaluation of mental health integration in the neglected tropical diseases program in Zamfara, North-west Nigeria. International health [Internet]. 2024;16(Supplement_1):i52-i59. Available from: https://academic.oup.com/inthealth/article/16/Supplement_1/i52/7636815?login=false
Type
1.
Mora JAU, Angarita PD. Leprosy in Colombia: A look from life experience. International health [Internet]. 2024;16(Supplement_1):i9-i11. Available from: https://academic.oup.com/inthealth/article/16/Supplement_1/i9/7636801?login=false
Type
1.
Souza GC, de Oliveira PS, de Araujo PN, Santos FLD, da Silva JP, Santos K da S, et al. Experiences of social stigma of people living with Hansen’s disease in Brazil: silencing, secrets and exclusion. International health [Internet]. 2024;16(Supplement_1):i60-i67. Available from: https://academic.oup.com/inthealth/article/16/Supplement_1/i60/7636805?login=false
Type
1.
Duck M. Let them talk and we listen: what are diseases of neglected people?. International health [Internet]. 2024;16(Supplement_1):i5-i6. Available from: https://academic.oup.com/inthealth/article/16/Supplement_1/i5/7636804?login=false
Type
1.
Campbell PO, Bauro T, Rimon E, Timeon E, Bland C, Ioteba N, et al. Single-Dose Rifampicin Leprosy Chemoprophylaxis for Household Contacts in Kiribati: An Audit of a Combined Retrospective and Prospective Approach. Tropical medicine and infectious disease [Internet]. 2024;9(3):1-11. Available from: https://www.mdpi.com/2414-6366/9/3/58/pdf?version=1709286138
Type
1.
Farhan R, AbdullGaffar B, Al-Dabal L. Concomitant Tuberculous and Lepromatous Lymphadenitis: Clues and Pitfalls of Leprosy Concealed by Tuberculosis in Lymph Nodes. International journal of surgical pathology. 2024;.
Type
1.
Patel H, Pundkar A, Shrivastava S, Goyal S, Chandanwale R. Navigating Foot Tuberculosis in a Leprosy Survivor: A Case Managed Solely With Medical Strategies. Cureus [Internet]. 2024;16(2):1-7. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10928463/pdf/cureus-0016-00000053991.pdf